This document is an excerpt from the EUR-Lex website
Document 62019TA0678
Case T-678/19: Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel) (EU trade mark — Invalidity proceedings — International registration designating the European Union — Figurative mark Enterosgel — No bad faith — Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
Case T-678/19: Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel) (EU trade mark — Invalidity proceedings — International registration designating the European Union — Figurative mark Enterosgel — No bad faith — Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
Case T-678/19: Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel) (EU trade mark — Invalidity proceedings — International registration designating the European Union — Figurative mark Enterosgel — No bad faith — Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
OJ C 310, 2.8.2021, p. 22–22
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
2.8.2021 |
EN |
Official Journal of the European Union |
C 310/22 |
Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel)
(Case T-678/19) (1)
(EU trade mark - Invalidity proceedings - International registration designating the European Union - Figurative mark Enterosgel - No bad faith - Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
(2021/C 310/26)
Language of the case: English
Parties
Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, M. Stępień and A. Przytuła, lawyers)
Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Bioline Pharmaceutical AG (Baar, Switzerland) (represented by: T. Grucelski, H. Gajek and M. Furmańska, lawyers)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 (Case R 482/2018-4), relating to invalidity proceedings between Health Product Group and Bioline Pharmaceutical.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Health Product Group sp. z o.o. to pay the costs. |